SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 257.66 |
| Enterprise Value ($M) | 248.64 |
| Book Value ($M) | 1.25 |
| Book Value / Share | 0.04 |
| Price / Book | 205.64 |
| NCAV ($M) | -1.35 |
| NCAV / Share | -0.04 |
| Price / NCAV | -190.44 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -5.25 |
| Return on Assets (ROA) | -1.19 |
| Return on Equity (ROE) | -1.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.00 |
| Current Ratio | 1.00 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 9.21 |
| Assets | 11.82 |
| Liabilities | 10.57 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -8.89 |
| Net Income | -16.48 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -6.40 |
| Cash from Investing | -0.49 |
| Cash from Financing | 13.79 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 27,082 | 59,157 | 45.78 | |
| 16,708 | 60,287 | 27.71 | |
| 12,855 | 38,386 | 33.49 | |
| 5,998 | 7,790 | 77.00 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ETNB – 89bio, Inc. | ETON – Eton Pharmaceuticals, Inc. |
| FATE – Fate Therapeutics, Inc. | FHTX – Foghorn Therapeutics Inc. |
| FOLD – Amicus Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io